On Wednesday, Shares of National Bank of Greece S.A. (NYSE:NBG), lost -7.43% to $0.88, hitting its lowest level,
The country requested a three year loan from its creditors recently, but offered no details on what actions it would take in return to strengthen the government’s finances, The New York Times reports.
Greece formally requested new aid in order to keep from defaulting on its massive debt and hinted to its willingness to alter its tax and pension systems.
The Eurozone has given Greece until Thursday to present a new proposal in order to secure a deal with its international creditors, BBC.com reports. A full EU summit will be held on Sunday where leaders will decide on a deal.
National Bank of Greece S.A., together with its auxiliaries, provides diversified financial services. The company is involved in retail and commercial banking, asset administration, investment banking, brokerage, and insurance activities.
Shares of Amedica Corporation (NASDAQ:AMDA), declined -14.77% to $0.47, during its last trading session.
Amedica Corporation, declared that responses to the U.S. Food and Drug Administration (“FDA”) inquiries regarding the Company’s cervical composite silicon nitride interbody device were presented to the FDA on June 30, 2015. Additionally, the Company has received feedback from the FDA regarding its wear testing femoral head protocols.
Submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding, which was presented in the first quarter of 2015, relates to the Company’s CASCADE clinical trial of its composite silicon nitride spinal interbody devices. Since submission, the Company received a list of questions from the FDA requesting additional information pertaining to the product’s clinical performance data, in addition to indications for use and device description. The Company has responded to the questions and now awaits clearance of the Class II medical device for commercial distribution or additional communication from the FDA.
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America.
Finally, Extra Space Storage Inc. (NYSE:EXR), ended its last trade with 0.39% gain, and closed at $68.81.
Extra Space Storage, declared a realignment of its executive team. Charles L. Allen, the Company’s Executive Vice President and Chief Investment Officer (“CIO”), will step down as CIO. Mr. Allen will continue in his duties as an Executive Vice President focusing on strategy and execution of complex transactions, counting acquisitions involving operating partnership units. Mr. Allen has been part of the Company’s administration team since 1998, and has served as General Counsel, Chief Legal Officer (“CLO”) and CIO. The Company has designated Joseph D. Margolis, as the Company’s CIO effective right away.
Mr. Margolis has served as a member of the Company’s board of directors since February 2005 and will resign from the board in connection with joining the Company as CIO. Concurrently with his resignation from the board, Mr. Margolis is resigning from the Audit Committee and the Compensation, Nominating and Governance Committee of the board. From 2011 until his appointment as the Company’s CIO, Mr. Margolis served as Senior Managing Director and Partner at Penzance Properties in the Washington, D.C. metro area. Formerly, Mr. Margolis was a co-founding partner of Arsenal Real Estate Funds from 2004 through 2011. Before forming Arsenal, Mr. Margolis held senior positions at Prudential Real Estate Investors from 1992 to 2004 in portfolio administration, capital markets and as General Counsel. Mr. Margolis is a graduate of Harvard College and Columbia University School of Law.
Extra Space Storage, Inc. operates as a real estate investment trust (REIT) in the United States. It engages in property administration and development activities that comprise acquiring, managing, developing, and selling, in addition to the rental of self-storage facilities.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
